Identifying and definitional attributes
|Metadata item type:||Indicator|
|Indicator type:||Progress measure|
|Short name:||PI 02–Incidence of selected cancers, 2020|
|Registration status:||Health, Standardisation pending 29/11/2019|
Incidence of selected cancers of public health importance.
|Indicator set:||National Healthcare Agreement (2020) Health, Standardisation pending 29/11/2019|
|Outcome area:||Prevention Health, Standard 07/07/2010|
Collection and usage attributes
Rates directly age-standardised to the 2001 Australian Standard Population.
Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) are based on the Statistical Area Level 2 (SA2) of the person at the time of their diagnosis.
Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published.
100,000 × (Numerator ÷ Denominator)
Calculated separately for each type of cancer.
For melanoma, bowel and lung cancer: Number of new cases in the reported year.
For cervical and breast cancer in females: Number of new cases in females in the reported year.
|Numerator data elements:|
For melanoma, bowel and lung cancer: Total population.
For cervical and breast cancer in females: Total female population.
|Denominator data elements:|
2015, 2016, 2017 — State and territory, by:
2015, 2016, 2017 — Nationally, by:
Cancer types in these disaggregations comprise: bowel cancer (ICD-10 2016 version codes C18–C20), lung cancer (C33–C34), melanoma of the skin (C43), female breast cancer (C50) and cervical cancer (C53).
Note: The 2015 tables supplied for 2019 National Healthcare Agreement performance reporting did not include data for New South Wales (NSW). These will be resupplied for 2020 performance reporting with the inclusion of NSW data.
Northern Territory data for 2016 is not yet available and is therefore not included in the 2016 tables.
The 2017 tables only include data from those jurisdictions from which it is available: Victoria and Western Australia (WA).
Some disaggregation may result in numbers too small for publication.
Disaggregation by remoteness area is subject to availability of suitable population data.
|Disaggregation data elements:|
Most recent data available for 2020 National Healthcare Agreement performance reporting: 2017 for Victoria and WA; 2016 for NSW, Queensland, SA, Tasmania and the Australian Capital Territory; and 2015 for the Northern Territory.
|Unit of measure:||Episode|
Indicator conceptual framework
|Framework and dimensions:||Health conditions|
Data source attributes
National Healthcare Agreement
|Organisation responsible for providing data:|
Australian Institute of Health and Welfare
|Further data development / collection required:|
Specification: Final, the measure meets the intention of the indicator.
|Related metadata references:|
See also Australian Health Performance Framework: PI 2.1.5–Survival of people diagnosed with cancer, 2019 Health, Standardisation pending 03/12/2019
See also Australian Health Performance Framework: PI 3.1.2–Incidence of selected cancers, 2019 Health, Standardisation pending 03/12/2019
Supersedes National Healthcare Agreement: PI 02–Incidence of selected cancers, 2019 Health, Standard 19/06/2019
See also National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2020 Health, Standardisation pending 29/11/2019